To achieve this, we performed enrichment analysis of 332 ENCODE‐derived TFs at differentially methylated CpGs (DMCs) in AML patients with DNMT3A or IDH2 mutations, analyzing each mutation subgroup separately. The gene discussed is IDH2; the disease is acute myeloid leukemia.